This week at Newcastle University's Medical School, news broke about the success of the Moderna-sponsored ConquerRSV vaccine clinical trial – a testament to the ever-evolving landscape of healthcare and the potential impact of Newcastle's research on global health challenges.

Respiratory syncytial virus (RSV) is a common respiratory illness that typically causes mild, cold-like symptoms. However, for infants, young children, and those with compromised immune systems, RSV can lead to serious lower respiratory infections such as bronchiolitis and pneumonia.

There's currently no specific treatment for RSV, and until recently, no effective preventative vaccines were available. 

Newcastle University's Medical School offers an unparalleled opportunity to be at the forefront of medical discovery while gaining crucial clinical experience.  If you're passionate about medicine and eager to contribute to the future of healthcare, then Newcastle University is the place for you.

Ready to Learn More? Book a Consultation By Clicking The Button Below!

Source: https://www.ncl.ac.uk/press/articles/latest/2024/03/rsvvaccine/